These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16878320)

  • 21. Glycogen synthase kinase 3beta links neuroprotection by 17beta-estradiol to key Alzheimer processes.
    Goodenough S; Schleusner D; Pietrzik C; Skutella T; Behl C
    Neuroscience; 2005; 132(3):581-9. PubMed ID: 15837120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein.
    Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M
    J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3β.
    Kawakami F; Shimada N; Ohta E; Kagiya G; Kawashima R; Maekawa T; Maruyama H; Ichikawa T
    FEBS J; 2014 Jan; 281(1):3-13. PubMed ID: 24165324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The involvement of glycogen synthase kinase-3 and protein phosphatase-2A in lactacystin-induced tau accumulation.
    Ren QG; Liao XM; Wang ZF; Qu ZS; Wang JZ
    FEBS Lett; 2006 May; 580(10):2503-11. PubMed ID: 16638578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
    Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F
    J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycogen synthase kinase 3beta phosphorylates p21WAF1/CIP1 for proteasomal degradation after UV irradiation.
    Lee JY; Yu SJ; Park YG; Kim J; Sohn J
    Mol Cell Biol; 2007 Apr; 27(8):3187-98. PubMed ID: 17283049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
    Wang JZ; Grundke-Iqbal I; Iqbal K
    Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress.
    Poppek D; Keck S; Ermak G; Jung T; Stolzing A; Ullrich O; Davies KJ; Grune T
    Biochem J; 2006 Dec; 400(3):511-20. PubMed ID: 16939415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A.
    Li L; Liu Z; Liu J; Tai X; Hu X; Liu X; Wu Z; Zhang G; Shi M; Zhao G
    Neurobiol Dis; 2013 Jun; 54():320-8. PubMed ID: 23321003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant tau phosphorylation by glycogen synthase kinase-3beta and JNK3 induces oligomeric tau fibrils in COS-7 cells.
    Sato S; Tatebayashi Y; Akagi T; Chui DH; Murayama M; Miyasaka T; Planel E; Tanemura K; Sun X; Hashikawa T; Yoshioka K; Ishiguro K; Takashima A
    J Biol Chem; 2002 Nov; 277(44):42060-5. PubMed ID: 12191990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination.
    Luo HB; Xia YY; Shu XJ; Liu ZC; Feng Y; Liu XH; Yu G; Yin G; Xiong YS; Zeng K; Jiang J; Ye K; Wang XC; Wang JZ
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16586-91. PubMed ID: 25378699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bip enhanced the association of GSK-3β with tau during ER stress both in vivo and in vitro.
    Liu ZC; Fu ZQ; Song J; Zhang JY; Wei YP; Chu J; Han L; Qu N; Wang JZ; Tian Q
    J Alzheimers Dis; 2012; 29(4):727-40. PubMed ID: 22460328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of EphB2 attenuates tau phosphorylation through PI3K/Akt-mediated inactivation of glycogen synthase kinase-3β.
    Jiang J; Wang ZH; Qu M; Gao D; Liu XP; Zhu LQ; Wang JZ
    Sci Rep; 2015 Jun; 5():11765. PubMed ID: 26119563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3.
    Lovell MA; Xiong S; Xie C; Davies P; Markesbery WR
    J Alzheimers Dis; 2004 Dec; 6(6):659-71; discussion 673-81. PubMed ID: 15665406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration.
    Leroy K; Yilmaz Z; Brion JP
    Neuropathol Appl Neurobiol; 2007 Feb; 33(1):43-55. PubMed ID: 17239007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation.
    Ambegaokar SS; Jackson GR
    Hum Mol Genet; 2011 Dec; 20(24):4947-77. PubMed ID: 21949350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide induces tau hyperphosphorylation via glycogen synthase kinase-3beta activation.
    Zhang YJ; Xu YF; Liu YH; Yin J; Wang JZ
    FEBS Lett; 2005 Nov; 579(27):6230-6. PubMed ID: 16253246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rho-kinase ROCK inhibitors reduce oligomeric tau protein.
    Hamano T; Shirafuji N; Yen SH; Yoshida H; Kanaan NM; Hayashi K; Ikawa M; Yamamura O; Fujita Y; Kuriyama M; Nakamoto Y
    Neurobiol Aging; 2020 May; 89():41-54. PubMed ID: 31982202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual effects of PKNalpha and protein kinase C on phosphorylation of tau protein by glycogen synthase kinase-3beta.
    Isagawa T; Mukai H; Oishi K; Taniguchi T; Hasegawa H; Kawamata T; Tanaka C; Ono Y
    Biochem Biophys Res Commun; 2000 Jun; 273(1):209-12. PubMed ID: 10873588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of PAR-1 kinase and stimulation of tau phosphorylation by diverse signals require the tumor suppressor protein LKB1.
    Wang JW; Imai Y; Lu B
    J Neurosci; 2007 Jan; 27(3):574-81. PubMed ID: 17234589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.